You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CXCR4 mutation

Showing 1 - 25 of 5,885
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Thymoma Trial in Beijing (68Ga-Pentixafor)

Recruiting
  • Thymoma
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Oct 11, 2023

Aldosterone-Producing Adenoma Trial (CXCR4)

Not yet recruiting
  • Aldosterone-Producing Adenoma
  • CXCR4
  • (no location specified)
Apr 20, 2023

Waldenstrom's Macroglobulinemia Trial in Boston (Ulocuplumab, Ibrutinib)

Active, not recruiting
  • Waldenstrom's Macroglobulinemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jun 20, 2022

Vasculitis, Diagnoses Disease Trial in Würzburg (CXCR4-PET)

Recruiting
  • Vasculitis
  • Diagnoses Disease
  • CXCR4-PET
  • Würzburg, Bayern, Germany
    Departement of Internal Medicine II, Rheumatology/Clinical Immun
Dec 4, 2022

Hiv Trial in Philadelphia (Autologous CD4 T-Cells)

Completed
Has Results
  • Hiv
  • Autologous CD4 T-Cells
  • Philadelphia, Pennsylvania
    University of Pennsylvania
Nov 13, 2022

Tumor Malignant Trial in Napoli (CLG)

Active, not recruiting
  • Neoplasm Malignant
  • CLG
  • Napoli, Italy
  • +1 more
Apr 18, 2023

CXCR4, PET/CT, Hematological Malignancy Trial in Wuhan (68Ga-pentixafor, PET/CT)

Not yet recruiting
  • CXCR4
  • +2 more
  • Wuhan, Hubei, China
    Zhongnan Hospital of Wuhan University
Feb 15, 2022

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in New York ([68Ga]-Pentixafor)

Recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 4, 2022

Metastatic Pancreatic Adenocarcinoma, Recurrent Pancreatic Adenocarcinoma, Stage IV Pancreatic Cancer AJCC v6 and v7 Trial in

Active, not recruiting
  • Metastatic Pancreatic Adenocarcinoma
  • +2 more
  • CXCR4 Antagonist BL-8040
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 9, 2022

Marginal Zone Lymphoma Trial ([68Ga]Ga-PentixaFor, [18F]Fluorodeoxyglucose)

Not yet recruiting
  • Marginal Zone Lymphoma
  • (no location specified)
Nov 6, 2023

Advanced Malignant Solid Tumor, EGFR Gene Amplification, EGFR Gene Mutation Trial in Houston (Everolimus, Neratinib,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Fabry Disease Trial in Taipei

Recruiting
  • Fabry Disease
    • Taipei, Taiwan
      Investigational Site Number :1580001
    Sep 24, 2023

    Sickle Cell Disease Trial in Saint Louis (Motixafortide, Natalizumab, Leukapheresis)

    Not yet recruiting
    • Sickle Cell Disease
    • Saint Louis, Missouri
      Washington University School of Medicine
    Nov 8, 2022

    Advanced Solid Tumor, Metastatic Solid Tumor, NSCLCs Trial (PRT3789)

    Recruiting
    • Advanced Solid Tumor
    • +3 more
    • Fairfax, Virginia
      NEXT Virginia
    Feb 1, 2023

    TRPV4 Gene Mutation Trial

    Not yet recruiting
    • TRPV4 Gene Mutation
      • (no location specified)
      Jan 9, 2023

      Aldosterone-Producing Adenoma Trial in Chengdu ([18F]AlF-NOTA-pentixather PET/CT)

      Recruiting
      • Aldosterone-Producing Adenoma
      • [18F]AlF-NOTA-pentixather PET/CT
      • Chengdu, Sichuan, China
        Sichuan Academy of Medical Sciences.Sichuan Provincial People's
      Apr 3, 2023

      Multiple Myeloma Trial (CXCR4 modified anti-BCMA CAR T cells)

      Not yet recruiting
      • Multiple Myeloma
      • CXCR4 modified anti-BCMA CAR T cells
      • (no location specified)
      Apr 7, 2021

      Trial

      Not yet recruiting
      • Leber Hereditary Optic Neuropathy (LHON)
      • NR082 Injection
      • Injection needle
      • (no location specified)
      Jan 30, 2023

      An Intervention to Increase Genetic Testing in Families Who May

      Recruiting
      • BRCA1 Mutation
      • +21 more
      • Intervention Arm At-risk Relative/ARR Contacts
      • +5 more
      • Basking Ridge, New Jersey
      • +7 more
      Nov 22, 2022

      Lymphoma, Multiple Myeloma, Leukemia Trial in Fuzhou (68Ga-Pentixafor)

      Recruiting
      • Lymphoma
      • +2 more
      • Fuzhou, Fujian, China
        Department of Nuclear Medicine, First Affiliated Hospital of Fuj
      Apr 6, 2021

      Factors Influencing Cascade Testing Among Hereditary

      Recruiting
      • Breast Carcinoma
      • +8 more
      • Interview
      • +2 more
      • Birmingham, Alabama
      • +1 more
      Jun 22, 2022

      Hereditary Haemorrhagic Telangiectasia Trial in Bron, Clermont-Ferrand, Montpellier (Cord blood sampling, Cord sampling)

      Not yet recruiting
      • Hereditary Haemorrhagic Telangiectasia
      • Cord blood sampling
      • Cord sampling
      • Bron, France
      • +2 more
      Nov 21, 2022

      BRCA1 Gene Mutation, BRCA2 Gene Mutation, Ovarian Serous Adenocarcinoma Trial in Buffalo, New York (biological, other, drug)

      Active, not recruiting
      Has Results
      • BRCA1 Gene Mutation
      • +5 more
      • Durvalumab
      • +3 more
      • Buffalo, New York
      • +1 more
      Jan 20, 2023

      Clinical Phenotypic Characteristics of SC26A4

      Recruiting
      • Hearing Loss
      • Pendred Syndrome
        • Beijing, Beijing, China
          Chinese PLA General Hospital
        Jul 24, 2023

        Leptomeningeal Metastasis, NSCLC Stage IV, Melanoma Stage IV Trial in Geneva, St Gallen, Zurich (intrathecal nivolumab and

        Recruiting
        • Leptomeningeal Metastasis
        • +2 more
        • intrathecal nivolumab and intrathecal ipilimumab
        • Geneva, Switzerland
        • +2 more
        Dec 18, 2022